LBP-029 Efficacy and safety of 144 weeks of bulevirtide 2 mg or 10 mg monotherapy from the ongoing phase 3 study, MYR301

Saved in:
Bibliographic Details
Published in:Journal of hepatology 2024-06, Vol.80, p.S92-S92
Main Authors: Lampertico, Pietro, Aleman, Soo, Brunetto, Maurizia, Blank, Antje, Andreone, Pietro, Bogomolov, Pavel, Chulanov, Vladimir, Mamonova, Nina, Geyvandova, Natalia, Morozov, Viacheslav, Sagalova, Olga, Stepanova, Tatyana, Chee, Grace M., Manuilov, Dmitry, Li, Mingyang, Tseng, Steve, Lau, Audrey, Osinusi, Anu, zur Wiesch, Julian Schulze, Cornberg, Markus, Zeuzem, Stefan, Wedemeyer, Heiner
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0168-8278
1600-0641
DOI:10.1016/S0168-8278(24)00596-8